Laboratory Analytical Instruments - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Laboratory industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Laboratory Analytical Instruments - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Laboratory Analytical Instruments
Corporate Insider Buy Sell Ratio (Insider Count) - Laboratory Analytical Instruments
Laboratory Analytical Instruments - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-02-24 MTD / Mettler-Toledo International Inc. 4 Magloth Christian M - Exercise D 397.95 790
2025-02-24 AVTR / Avantor, Inc. 4 Couturier Christophe F - Taxes D 17.47 -750
2025-02-24 AVTR / Avantor, Inc. 4 Bramwell James F - Taxes D 17.47 -2,181
2025-02-24 AVTR / Avantor, Inc. 4 Hankamer Brittany F - Taxes D 17.47 -437
2025-02-24 AVTR / Avantor, Inc. 4 Eck Steven W F - Taxes D 17.47 -439
2025-02-24 AVTR / Avantor, Inc. 4 Stubblefield Michael F - Taxes D 17.47 -6,800
2025-02-23 AVTR / Avantor, Inc. 4 Couturier Christophe F - Taxes D 17.30 -1,506
2025-02-23 AVTR / Avantor, Inc. 4 Stubblefield Michael F - Taxes D 17.30 -14,674
2025-02-23 AVTR / Avantor, Inc. 4 Eck Steven W F - Taxes D 17.30 -1,956
2025-02-23 AVTR / Avantor, Inc. 4 Sokenu Claudius F - Taxes D 17.30 -2,318
2025-02-23 AVTR / Avantor, Inc. 4 Hankamer Brittany F - Taxes D 17.30 -1,537
2025-02-23 AVTR / Avantor, Inc. 4 Bramwell James F - Taxes D 17.30 -3,443
2025-02-23 AVTR / Avantor, Inc. 4 Gourdier Benoit F - Taxes D 17.30 -2,842
2025-02-21 TXG / 10x Genomics, Inc. 4 Mateo Alan P - Purchase D 11.1393 40,000
2025-02-20 AVTR / Avantor, Inc. 4 Couturier Christophe A - Award D 12,864
2025-02-20 AVTR / Avantor, Inc. 4 Stubblefield Michael A - Award D 157,232
2025-02-20 AVTR / Avantor, Inc. 4 Eck Steven W A - Award D 18,867
2025-02-20 AVTR / Avantor, Inc. 4 Hankamer Brittany A - Award D 17,152
2025-02-20 AVTR / Avantor, Inc. 4 Sokenu Claudius A - Award D 21,440
2025-02-20 AVTR / Avantor, Inc. 4 Gourdier Benoit A - Award D 35,734
2025-02-20 AVTR / Avantor, Inc. 4 Jones R. Brent A - Award D 37,164
2025-02-20 AVTR / Avantor, Inc. 4 Jones R. Brent A - Award D 42,881
2025-02-18 PACB / Pacific Biosciences of California, Inc. 4 HENRY CHRISTIAN O S - Sale D 1.878 -259,909
2025-02-18 PACB / Pacific Biosciences of California, Inc. 4 Van Oene Mark S - Sale D 1.878 -100,773
2025-02-18 PACB / Pacific Biosciences of California, Inc. 4 Farmer Michele S - Sale D 1.878 -24,349
2025-02-18 BRKR / Bruker Corporation 4 LAUKIEN FRANK H P - Purchase D 50.75 13,063
2025-02-18 BRKR / Bruker Corporation 4 LAUKIEN FRANK H P - Purchase D 51.23 6,937
2025-02-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 2,016
2025-02-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 6,758
2025-02-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 1,981
2025-02-18 RVTY / Revvity, Inc. 4 Krakowiak Maxwell F - Taxes D 112.26 -50
2025-02-18 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 5.31 -588
2025-02-18 RVTY / Revvity, Inc. 4 Gonzales Anita F - Taxes D 112.26 -50
2025-02-18 RVTY / Revvity, Inc. 4 Gonzales Anita F - Taxes D 112.26 -83
2025-02-18 RVTY / Revvity, Inc. 4 Gonzales Anita F - Taxes D 112.26 -69
2025-02-18 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 5.31 -786
2025-02-18 SEER / Seer, Inc. 4 Farokhzad Omid F - Taxes D 2.30 -88,494
2025-02-18 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 5.31 -2,004
2025-02-18 SEER / Seer, Inc. 4 Horn David R. F - Taxes D 2.30 -26,572
2025-02-18 ILMN / Illumina, Inc. 4 Wedel Christensen Jakob D - Sale to Issuer D 100.00 -460
2025-02-18 ILMN / Illumina, Inc. 4 Leckman Patricia D - Sale to Issuer D 100.00 -1,756
2025-02-18 RPID / Rapid Micro Biosystems, Inc. 4 Spignesi Robert G. Jr. A - Award D 365,000
2025-02-18 RPID / Rapid Micro Biosystems, Inc. 4 Wilson John J. Addington A - Award D 44,000
2025-02-18 RPID / Rapid Micro Biosystems, Inc. 4 WIRTJES SEAN M A - Award D 160,000
2025-02-15 ILMN / Illumina, Inc. 4 Pegels Kevin Carl F - Taxes D 101.09 -565
2025-02-15 QTRX / Quanterix Corporation 4 Toloue Masoud F - Taxes D 8.05 -752
2025-02-15 ILMN / Illumina, Inc. 4 Leckman Patricia F - Taxes D 101.09 -644
2025-02-15 BNGO / Bionano Genomics, Inc. 4 Dixon Jonathan V. F - Taxes D 5.73 -6
2025-02-15 BNGO / Bionano Genomics, Inc. 4 Borodkin Mark F - Taxes D 5.73 -20
2025-02-15 ILMN / Illumina, Inc. 4 Rollins Carissa F - Taxes D 101.09 -513
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)